| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
2 companies
Berger Mark Stanley is a Chief Medical Officer at GNPX with holdings across 2 companies. Recent SEC Form 4 filings include 1 buy and 0 sells.
Estimated insider holdings value: $55K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 15, 2017 | ATNM Actinium Pharmaceuticals, Inc. | Chief Medical Officer | Buy | 5,000 | $1.11 | $5,550.00 | New |